Related Experiment Video

Updated: May 28, 2026

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

The stem cell niche as a pharmaceutical target for prevention of skeletal metastases

John M Chirgwin1

  • 1Department of Medicine,Division of Endocrinology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. jmchirgw@iupui.edu

Anti-Cancer Agents in Medicinal Chemistry
|November 3, 2011
PubMed

Insights

Preventing advanced prostate and breast cancer metastasis to bone is possible by targeting tumor stem cells. Therapies promoting normal bone and blood cell growth may inhibit cancer spread, reducing patient mortality.

Area of Science:

  • Oncology
  • Bone Metastasis Research
  • Cancer Stem Cell Biology

Background:

  • Advanced prostate and breast cancers frequently metastasize to bone, leading to incurable conditions, significant morbidity, and mortality.
  • Bone metastasis is a lengthy process, offering a therapeutic window for intervention and prevention of disease progression.
  • The bone microenvironment, rich in hematopoietic and mesenchymal stem cells, is usurped by circulating tumor cells, promoting cancer growth.

Purpose of the Study:

  • To explore strategies for preventing the metastatic progression of advanced prostate and breast cancers to bone.
  • To investigate the potential of targeting tumor stem cell colonization of skeletal niches.
  • To identify therapeutic agents that could inhibit tumor growth in bone and delay metastatic spread.

Main Methods:

  • Analyzing the interaction between circulating tumor cells and normal stem cell niches within the bone microenvironment.
  • Investigating agents that stimulate normal hematopoiesis (blood cell formation) and osteogenesis (bone formation).
  • Proposing the development of high-throughput assays to screen compounds for their ability to suppress tumor stem cell occupation of bone niches.

Main Results:

  • Circulating tumor cells compete with normal stem cells for bone marrow niches.
  • Agents promoting normal hematopoiesis and bone formation show potential in inhibiting tumor stem cell colonization.
  • The study highlights the feasibility of developing assays to identify preventative therapies.

Conclusions:

  • Targeting the competition between tumor stem cells and normal stem cells in bone niches is a promising strategy for preventing bone metastasis.
  • Therapies that support normal bone and blood cell development could be crucial in managing advanced prostate and breast cancer.
  • Developing high-throughput screening methods can accelerate the discovery of novel agents to combat skeletal metastatic disease.

More Related Videos

Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate10:32

Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate

Published on: May 19, 2023

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Related Concept Videos

Stem Cell Niche01:26

Stem Cell Niche

The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...